News

The Japanese government discarded Covid-19 oral medicines believed to be worth around 240 billion yen (RM6.85 billion) in the ...
The Japanese government discarded Covid-19 oral medicines believed to be worth around 240 billion yen (US$1.6 billion) in the ...
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...